Access the full text.
Sign up today, get DeepDyve free for 14 days.
Morice Morice, Serruys Serruys, Sousa Sousa (2002)
Randomized study with the sirolimus‐coated BX velocity balloon‐expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularizationN Engl J Med, 346
Fen Wang, B. Uretsky, J. Freeman, Dong Zhang, S. Giordano, J. Goodwin (2008)
Survival advantage in Medicare patients receiving drug‐eluting stents compared with bare metal stents: Real or artefactual?Catheterization and Cardiovascular Interventions, 71
A. Ong, P. Serruys, F. Mohr, M. Morice, A. Kappetein, D. Holmes, M. Mack, M. brand, M. Morel, G. Es, J. Kleijne, J. Koglin, M. Russell (2006)
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.American heart journal, 151 6
A. Dibra, A. Kastrati, J. Mehilli, J. Pache, H. Schühlen, N. Beckerath, K. Ulm, R. Wessely, J. Dirschinger, A. Schömig (2005)
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.The New England journal of medicine, 353 7
A. Schömig, A. Dibra, S. Windecker, J. Mehilli, J. Lezo, C. Kaiser, Seung‐Jung Park, J. Goy, Jae‐Hwan Lee, E. Lorenzo, Jinjin Wu, P. Jüni, M. Pfisterer, B. Meier, A. Kastrati (2007)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.Journal of the American College of Cardiology, 50 14
D. Baumgart, V. Klauss, F. Baer, F. Hartmann, H. Drexler, W. Motz, H. Klues, S. Hofmann, Wolfgang Völker, T. Pfannebecker, H. Stoll, G. Nickenig (2007)
One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.Journal of the American College of Cardiology, 50 17
T. Chechi, G. Vittori, G. Zoccai, S. Vecchio, E. Falchetti, G. Spaziani, G. Baldereschi, C. Giglioli, S. Valente, M. Margheri (2007)
Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).Journal of interventional cardiology, 20 4
D. Kandzari, M. Leon, J. Popma, P. Fitzgerald, C. O'shaughnessy, M. Ball, M. Turco, R. Applegate, P. Gurbel, M. Midei, Sejal Badre, L. Mauri, Kweli Thompson, L. Lenarz, R. Kuntz (2006)
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.Journal of the American College of Cardiology, 48 12
J. Mehilli, A. Dibra, A. Kastrati, J. Pache, J. Dirschinger, A. Schömig (2006)
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.European heart journal, 27 3
T. Palmerini, F. Barlocco, A. Santarelli, L. Bacchi-Reggiani, C. Savini, E. Baldini, Laura Alessi, M. Ruffini, G. Credico, G. Piovaccari, R. Bartolomeo, A. Marzocchi, A. Branzi, S. Servi (2007)
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years).European heart journal, 28 22
A. Kastrati, J. Mehilli, N. Beckerath, A. Dibra, J. Hausleiter, J. Pache, H. Schühlen, C. Schmitt, J. Dirschinger, A. Schömig (2005)
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.JAMA, 293 2
A. Kastrati, A. Dibra, C. Spaulding, G. Laarman, M. Menichelli, M. Valgimigli, E. Lorenzo, C. Kaiser, I. Tierala, J. Mehilli, M. Seyfarth, O. Varenne, M. Dirksen, G. Percoco, A. Varricchio, U. Pittl, M. Syvänne, M. Suttorp, R. Violini, A. Schömig (2007)
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.European heart journal, 28 22
D. Kumbhani, A. Bavry, Apur Kamdar, T. Helton, Deepak Bhatt (2008)
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.American heart journal, 155 4
David Williams, J. Abbott, K. Kip (2006)
Outcomes of 6906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: Report of the DEScover RegistryCirculation, 114
E. Meliga, H. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A. Maree, S. Cook, L. Reardon, C. Moretti, S. Servi, I. Palacios, S. Windecker, A. Colombo, R. Domburg, I. Sheiban, P. Serruys (2008)
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.Journal of the American College of Cardiology, 51 23
M. Suttorp, G. Laarman (2007)
A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study.American heart journal, 154 3
L. Thuesen, H. Kelbaek, L. Kløvgaard, S. Helqvist, E. Jørgensen, Samir Aljabbari, L. Krusell, G. Jensen, H. Bøtker, K. Saunamäki, J. Lassen, A. Weert (2006)
Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).American heart journal, 152 6
J. Goy, J. Stauffer, M. Siegenthaler, A. Benoît, C. Seydoux (2005)
A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial.Journal of the American College of Cardiology, 45 2
P. Vermeersch, P. Agostoni, S. Verheye, P. Heuvel, C. Convens, F. Branden, G. Langenhove (2007)
Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.Journal of the American College of Cardiology, 50 3
Bas Hoeven, S. Liem, J. Jukema, Navin Suraphakdee, H. Putter, J. Dijkstra, D. Atsma, M. Bootsma, K. Zeppenfeld, P. Oemrawsingh, E. Wall, M. Schalij (2008)
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.Journal of the American College of Cardiology, 51 6
G. Stone, S. Ellis, C. O'shaughnessy, Steven Martin, L. Satler, T. Mcgarry, M. Turco, D. Kereiakes, Lynne Kelley, J. Popma, M. Russell (2006)
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.JAMA, 295 11
G. Stone, S. Ellis, D. Cox, J. Hermiller, C. O'shaughnessy, J. Mann, M. Turco, R. Caputo, P. Bergin, Joel Greenberg, J. Popma, M. Russell (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.The New England journal of medicine, 350 3
J. Cosgrave, G. Melzi, S. Corbett, G. Biondi‐Zoccai, R. Babic, F. Airoldi, A. Chieffo, G. Sangiorgi, M. Montorfano, I. Michev, M. Carlino, A. Colombo (2007)
Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.American heart journal, 153 3
Dibra Dibra, Kastrati Kastrati, Alfonso Alfonso (2007)
Effectiveness of drug‐eluting stents in patients with bare‐metal in‐stent restenosisJ Am Coll Cardiol, 49
P. Vermeersch, P. Agostoni, S. Verheye, P. Heuvel, C. Convens, N. Bruining, F. Branden, G. Langenhove (2006)
Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.Journal of the American College of Cardiology, 48 12
M. Hong, G. Mintz, Cheol-Whan Lee, Jong-Min Song, K. Han, D. Kang, Jae-Kwan Song, Jae‐Joong Kim, N. Weissman, N. Fearnot, Seong-Wook Park, Seung‐Jung Park (2003)
Paclitaxel Coating Reduces In-Stent Intimal Hyperplasia in Human Coronary Arteries: A Serial Volumetric Intravascular Ultrasound Analysis From the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)Circulation: Journal of the American Heart Association, 107
G. Gioia, A. Benassi, Raghar Mohendra, Khaza Chowdhury, Iqbal Masood, W. Matthai (2008)
Lack of clinical long‐term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein graftsCatheterization and Cardiovascular Interventions, 72
M. Morice, P. Serruys, P. Barragan, C. Bode, G. Es, H. Stoll, David Snead, L. Mauri, D. Cutlip, E. Sousa (2007)
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.Journal of the American College of Cardiology, 50 14
M. Menichelli, A. Parma, E. Pucci, R. Fiorilli, F. Felice, M. Nazzaro, A. Giulivi, Domenico Alborino, A. Azzellino, R. Violini (2007)
Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).Journal of the American College of Cardiology, 49 19
C. Stettler, Simon Wandel, S. Allemann, A. Kastrati, M. Morice, A. Schömig, M. Pfisterer, G. Stone, M. Leon, J. Lezo, J. Goy, Seung‐Jung Park, M. Sabaté, M. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M. Dirksen, P. Červinka, A. Petronio, A. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, P. Jüni (2007)
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 370
M. Suttorp, G. Laarman, B. Rahel, J. Kelder, M. Bosschaert, F. Kiemeneij, J. Berg, E. Bal, B. Rensing, F. Eefting, E. Mast (2006)
Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): A Randomized Comparison of Bare Metal Stent Implantation With Sirolimus-Eluting Stent Implantation for the Treatment of Total Coronary OcclusionsCirculation, 114
J. Ormiston, M. Webster, Seif Jack, P. Ruygrok, J. Stewart, D. Scott, E. Currie, Monique Panther, Bronwyn Shaw, B. O'Shaughnessy (2006)
Drug‐eluting stents for coronary bifurcations: Bench testing of provisional side‐branch strategiesCatheterization and Cardiovascular Interventions, 67
C. Spaulding, J. Daemen, E. Boersma, D. Cutlip, P. Serruys (2007)
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.The New England journal of medicine, 356 10
A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, H. Kelbaek, M. Menichelli, M. Sabaté, M. Suttorp, D. Baumgart, M. Seyfarth, M. Pfisterer, A. Schömig (2007)
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.The New England journal of medicine, 356 10
M. Morice, A. Colombo, B. Meier, P. Serruys, C. Tamburino, G. Guagliumi, E. Sousa, H. Stoll (2006)
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.JAMA, 295 8
A. Galløe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. Hansen, N. Bligaard, K. Saunamäki, A. Junker, J. Aarøe, U. Abildgaard, J. Ravkilde, T. Engstrøm, J. Jensen, H. Andersen, H. Bøtker, S. Galatius, S. Kristensen, J. Madsen, L. Krusell, S. Abildstrom, Ghita Stephansen, J. Lassen (2008)
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.JAMA, 299 4
S. Windecker, A. Remondino, F. Eberli, P. Jüni, L. Räber, P. Wenaweser, M. Togni, M. Billinger, D. Tüller, C. Seiler, M. Roffi, R. Corti, G. Sütsch, W. Maier, T. Lüscher, O. Hess, M. Egger, B. Meier (2005)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.The New England journal of medicine, 353 7
A. Erglis, I. Narbute, I. Kumsārs, S. Jēgere, I. Mintale, I. Zakke, U. Strazdiņš, A. Saltups (2007)
A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.Journal of the American College of Cardiology, 50 6
A. Maresta, E. Varani, M. Balducelli, F. Varbella, C. Lettieri, L. Uguccioni, P. Sangiorgio, G. Zoccai (2008)
Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).The American journal of cardiology, 101 11
M. Turco, J. Ormiston, J. Popma, L. Mandinov, C. O'shaughnessy, T. Mann, T. Mcgarry, Chiung‐Jen Wu, Charles Chan, M. Webster, J. Hall, G. Mishkel, L. Cannon, D. Baim, J. Koglin (2007)
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.Journal of the American College of Cardiology, 49 16
Togni Togni, Eber Eber, Widmer Widmer (2007)
Impact of vessel size on outcome after implantation of sirolimus‐eluting and paclitaxel‐eluting stents: A subgroup analysis of the SIRTAX trialJ Am Coll Cardiol, 50
S. Ellis, J. Popma, J. Lasala, J. Koglin, D. Cox, J. Hermiller, C. O'shaughnessy, J. Mann, M. Turco, R. Caputo, P. Bergin, Joel Greenberg, G. Stone (2005)
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.Journal of the American College of Cardiology, 45 8
A. Chieffo, Seung‐Jung Park, E. Meliga, I. Sheiban, Michael Lee, A. Latib, Young-Hak Kim, M. Valgimigli, D. Sillano, V. Magni, G. Biondi‐Zoccai, M. Montorfano, F. Airoldi, R. Rogacka, M. Carlino, I. Michev, Cheol-Whan Lee, M. Hong, Seong-Wook Park, C. Moretti, E. Bonizzoni, G. Sangiorgi, J. Tobis, P. Serruys, A. Colombo (2008)
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.European heart journal, 29 17
J. Moses, R. Mehran, E. Nikolsky, J. Lasala, Woodrow Corey, G. Albin, C. Hirsch, M. Leon, M. Russell, S. Ellis, G. Stone (2005)
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.Journal of the American College of Cardiology, 45 8
Y. Tsuchiya, A. Lansky, R. Costa, R. Mehran, Cody Pietras, Y. Shimada, S. Sonoda, Ecaterina Cristea, M. Negoita, G. Dangas, J. Moses, M. Leon, P. Fitzgerald, R. Müller, H. Störger, K. Hauptmann, E. Grube (2006)
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).The American journal of cardiology, 98 4
Fenwei Wang, G. Stouffer, S. Waxman, B. Uretsky (2002)
Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent eraCatheterization and Cardiovascular Interventions, 55
J. Fajadet, W. Wijns, G. Laarman, K. Kuck, J. Ormiston, T. Münzel, J. Popma, P. Fitzgerald, R. Bonan, R. Kuntz (2006)
Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II TrialCirculation, 114
A. Petronio, M. Carlo, G. Branchitta, B. Papini, N. Ciabatti, R. Gistri, B. Cortese, G. Gherarducci, A. Barsotti (2007)
Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.Journal of the American College of Cardiology, 49 5
E. Mahmud, Guilherme Bromberg-Marin, V. Palakodeti, Lawrence Ang, D. Creanga, A. DeMaria (2008)
Clinical ResearchInterventional CardiologyClinical Efficacy of Drug-Eluting Stents in Diabetic Patients: A Meta-AnalysisJournal of the American College of Cardiology, 51
Steve Lee, M. Price, G. Wong, R. Valencia, Samir Damani, N. Sawhney, Raghava Gollapudi, R. Schatz, P. Teirstein (2006)
Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure.The American journal of cardiology, 98 10
Cheol Lee, Sang-Hyun Kim, J. Suh, Duk‐Woo Park, Seung-Hwan Lee, Young-Hak Kim, M. Hong, Jae‐Joong Kim, Seong-Wook Park, Seung‐Jung Park (2008)
Long‐term clinical outcomes after sirolimus‐eluting stent implantation for treatment of restenosis within bare‐metal versus drug‐eluting stentsCatheterization and Cardiovascular Interventions, 71
R. Jeger, Stefan Schneiter, C. Kaiser, P. Bonetti, H. Rocca, M. Handke, S. Osswald, P. Buser, M. Pfisterer (2008)
Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel InterventionsCardiology, 112
D. Kereiakes, Hong Wang, J. Popma, R. Kuntz, Dennis Donohoe, J. Schofer, E. Schampaert, B. Meier, M. Leon, J. Moses (2006)
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.Journal of the American College of Cardiology, 48 1
Moo-Hyun Kim, S. Hong, K. Cha, H. Park, S. Chae, S. Hur, H. Gwon, J. Bae, D. Lim (2008)
Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.Journal of interventional cardiology, 21 3
A. Dibra, A. Kastrati, F. Alfonso, M. Seyfarth, M. Pérez-Vizcayno, J. Mehilli, A. Schömig (2007)
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.Journal of the American College of Cardiology, 49 5
J. Lasala, G. Stone, K. Dawkins, P. Serruys, A. Colombo, E. Grube, J. Koglin, S. Ellis (2006)
An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program.Journal of interventional cardiology, 19 5
Duk‐Woo Park, Seong-Wook Park, Kyoung-Ha Park, Bong-Ki Lee, Young-Hak Kim, Cheol-Whan Lee, M. Hong, Jae‐Joong Kim, Seung‐Jung Park (2006)
Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.The American journal of cardiology, 98 3
Seung‐Whan Lee, Seong-Wook Park, Young-Hak Kim, S. Yun, Duk‐Woo Park, Cheol-Whan Lee, M. Hong, K. Rhee, J. Chae, J. Ko, Jae‐Hyeong Park, Jae‐Hwan Lee, Si-Wan Choi, J. Jeong, I. Seong, Y. Cho, N. Lee, J. Kim, K. Chun, Hyun-Sook Kim, Seung‐Jung Park (2008)
A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.Journal of the American College of Cardiology, 52 9
P. Červinka, M. Costa, D. Angiolillo, R. Spacek, M. Bystroň, M. Kvašňák, J. Veselka, Hitesh Nanda, H. Futamatsu, Kino Futamatsu (2006)
“Head‐to‐head comparison between sirolimus‐eluting and paclitaxel‐eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”Catheterization and Cardiovascular Interventions, 67
C. Sheiban, C. Moretti, C. Spina, D. Sillano, P. Garrone, P. Lombardi, F. Sciuto, P. Omedè, G. Biondi-Zoccai, G. Trevi (2008)
Temporal trends in baseline characteristics and peri-procedural complications of percutaneous drug-eluting stent implantation for unprotected left main disease: a single high-volume center experience.Minerva cardioangiologica, 56 4
A. Buch, A. Javaid, D. Steinberg, P. Roy, Tina Slottow, Zhenyi Xue, Kimberly Smith, W. Suddath, L. Satler, K. Kent, A. Pichard, R. Waksman (2008)
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.The American journal of cardiology, 101 9
M. Morice, P. Serruys, J. Sousa, J. Fajadet, E.Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnár, R. Falotico (2002)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.The New England journal of medicine, 346 23
T. Mäkikallio, M. Niemelä, K. Kervinen, V. Jokinen, J. Laukkanen, K. Ylitalo, M. Tulppo, J. Juvonen, H. Huikuri (2008)
Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass graftingAnnals of Medicine, 40
G. Sianos, Michail Papafaklis, J. Daemen, S. Vaina, C. Mieghem, R. Domburg, L. Michalis, P. Serruys (2007)
Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.Journal of the American College of Cardiology, 50 7
E. Grube, S. Silber, K. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, M. Russell (2003)
TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary LesionsCirculation: Journal of the American Heart Association, 107
J. Daemen, H. Garcia-Garcia, N. Kukreja, Farshad Imani, P. Jaegere, G. Sianos, R. Domburg, P. Serruys (2006)
The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus.European heart journal, 28 1
Mahmud Mahmud, Bromberg‐Marin Bromberg‐Marin, Palakodeti Palakodeti (2008)
Clinical efficacy of drug‐eluting stents in diabetic patients: A meta‐analysisJ Am Coll Cardiol, 51
L. Campolo, P. Pantaleo, Maria Barattoni, A. Berardo, L. Ghetti, D. Fusco, A. Cremonesi, C. Grattoni, A. Marchese, V. Pernice, A. Alberti, E. Gliozheni, C. Perucci (2007)
RESTEM: a percutaneous coronary intervention ‘real world’ registry in the drug-eluting stent eraCoronary Artery Disease, 18
G. Biondi-Zoccai, M. Lotrionte, C. Moretti, E. Meliga, P. Agostoni, M. Valgimigli, A. Migliorini, D. Antoniucci, D. Carrié, G. Sangiorgi, A. Chieffo, A. Colombo, M. Price, P. Teirstein, E. Christiansen, A. Abbate, L. Testa, J. Gunn, F. Burzotta, A. Laudito, G. Trevi, I. Sheiban (2008)
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.American heart journal, 155 2
D. Holmes, P. Teirstein, L. Satler, M. Sketch, James O'Malley, J. Popma, R. Kuntz, P. Fitzgerald, Hong Wang, E. Caramanica, Sidney Cohen (2006)
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.JAMA, 295 11
H. Kelbaek, S. Helqvist, L. Thuesen, L. Kløvgaard, E. Jørgensen, K. Saunamäki, L. Krusell, H. Bøtker, T. Engstrøm, G. Jensen (2006)
Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.American heart journal, 152 5
M. Togni, S. Eber, J. Widmer, M. Billinger, P. Wenaweser, S. Cook, R. Vogel, C. Seiler, F. Eberli, W. Maier, R. Corti, M. Roffi, T. Lüscher, A. Garachemani, O. Hess, Simon Wandel, B. Meier, P. Jüni, S. Windecker (2007)
Clinical ResearchInterventional CardiologyImpact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the SIRTAX TrialJournal of the American College of Cardiology, 50
J. Torre-Hernández, F. Alfonso, F. Hernandez, J. Elízaga, M. Sanmartin, E. Pinar, Í. Lozano, J. Vázquez, J. Botas, A. Prado, J. Hernandez, J. Sanchis, J. Nodar, A. Gómez-Jaume, M. Larman, J. Diarte, J. Rodríguez-Collado, J. Rumoroso, J. López-Mínguez, J. Mauri (2008)
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).Journal of the American College of Cardiology, 51 10
Shaila Garg, Kimberly Smith, R. Torguson, Teruo Okabe, T. Slottow, D. Steinberg, P. Roy, Zhenyi Xue, N. Gevorkian, L. Satler, K. Kent, W. Suddath, A. Pichard, R. Waksman (2007)
Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stentCatheterization and Cardiovascular Interventions, 70
M. Sanmartin, J. Baz, Ramón Claro, Vanesa Asorey, D. Durán, G. Pradas, A. Íñiguez (2007)
Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease.The American journal of cardiology, 100 6
R. Moreno, C. Fernández, A. Sanchez-Recalde, G. Galeote, L. Calvo, F. Alfonso, R. Hernández, R. Sánchez-Aquino, D. Angiolillo, S. Villarreal, C. Macaya, J. López-Sendón (2007)
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.European heart journal, 28 13
Young-Hak Kim, Seong-Wook Park, Seung‐Whan Lee, Duk‐Woo Park, S. Yun, Cheol-Whan Lee, M. Hong, Hyun-Sook Kim, J. Ko, Jae‐Hyeong Park, Jae‐Hwan Lee, Si-Wan Choi, I. Seong, Y. Cho, N. Lee, J. Kim, K. Chun, Seung‐Jung Park (2006)
Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery DiseaseCirculation, 114
K. Seung, Duk‐Woo Park, Young-Hak Kim, Seung‐Whan Lee, Cheol-Whan Lee, M. Hong, Seong-Wook Park, S. Yun, H. Gwon, M. Jeong, Y. Jang, Hyo‐Soo Kim, P. Kim, I. Seong, H. Park, T. Ahn, I. Chae, S. Tahk, W. Chung, Seung‐Jung Park (2008)
Stents versus coronary-artery bypass grafting for left main coronary artery disease.The New England journal of medicine, 358 17
C. Simonton, B. Brodie, B. Cheek, F. Krainin, C. Metzger, J. Hermiller, Stanley Juk, Peter Duffy, Angela Humphrey, M. Nussbaum, Sherry Laurent (2007)
Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.Journal of the American College of Cardiology, 50 13
S. Pocock, A. Lansky, R. Mehran, J. Popma, M. Fahy, Yingbo Na, G. Dangas, J. Moses, T. Pucelikova, D. Kandzari, S. Ellis, M. Leon, G. Stone (2008)
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.Journal of the American College of Cardiology, 51 1
H. Garcia-Garcia, J. Daemen, N. Kukreja, Shuzou Tanimoto, C. Mieghem, M. Ent, R. Domburg, P. Serruys (2007)
Three‐year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus‐eluting stents: Insights from the rapamycin‐eluting stent evaluated at rotterdam cardiology hospital—(RESEARCH) registryCatheterization and Cardiovascular Interventions, 70
G. Stone, M. Midei, W. Newman, Mark Sanz, J. Hermiller, Jerome Williams, Naim Farhat, K. Mahaffey, D. Cutlip, P. Fitzgerald, P. Sood, Xiaolu Su, A. Lansky (2008)
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.JAMA, 299 16
With the advent of the second‐generation drug‐eluting stents, the decision process on which stent to use is becoming increasingly complex. Our article compares the technical characteristics of the four drug‐eluting stents (DES) currently available in the United States. We review the data that led to the approval of each stent and analyze the literature comparing their performance in various patient subgroups. Finally, we present our current practice and identify a “wish list” for the ideal DES.
Journal of Interventional Cardiology – Wiley
Published: Apr 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.